Built through global collaboration
TaiMed has built a global network spanning scientific discovery, clinical and product development, manufacturing, and commercialization. These relationships have helped advance CD4-targeted therapies from research through market and continue to inform the company's next generation of programs.
Scientific and research collaborators
TaiMed has worked with leading HIV and biomedical research institutions, including the Aaron Diamond AIDS Research Center, the National Institutes of Health, and The Rockefeller University, to access and advance differentiated antibody science.
Development and manufacturing collaborators
TaiMed works with experienced development and manufacturing organizations, including Samsung Biologics, Tanvex BioPharma, and other partners, to support biologics development and commercial supply.
Commercial partners
TaiMed has established commercialization relationships for Trogarzo in the United States and other markets, demonstrating the company's ability to execute partnerships across geographies.
Partner with TaiMed
TaiMed is interested in collaborations that can expand the potential of its CD4-targeted platform - including long-acting HIV combination development, selected in-licensing opportunities, regional commercialization, and scientific or platform collaborations.
Contact Business Development
TaiMed has built a global network spanning scientific discovery, clinical and product development, manufacturing, and commercialization. These relationships have helped advance CD4-targeted therapies from research through market and continue to inform the company's next generation of programs.
Scientific and research collaborators
TaiMed has worked with leading HIV and biomedical research institutions, including the Aaron Diamond AIDS Research Center, the National Institutes of Health, and The Rockefeller University, to access and advance differentiated antibody science.
Development and manufacturing collaborators
TaiMed works with experienced development and manufacturing organizations, including Samsung Biologics, Tanvex BioPharma, and other partners, to support biologics development and commercial supply.
Commercial partners
TaiMed has established commercialization relationships for Trogarzo in the United States and other markets, demonstrating the company's ability to execute partnerships across geographies.
Partner with TaiMed
TaiMed is interested in collaborations that can expand the potential of its CD4-targeted platform - including long-acting HIV combination development, selected in-licensing opportunities, regional commercialization, and scientific or platform collaborations.
Contact Business Development
Contact CDMO Service